Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung Cancer

Stopped early · Not applicable

Conditions studied: Non-small Cell Lung Cancer

In brief

The goal of this trial is to design and test a telehealth nurse navigation intervention for patients with suspected locally advanced/metastatic NSCLC to improve timely molecularly-informed treatment recommendations through early integration of concurrent molecular testing.

Key facts

Study ID

NCT05790460

Run by

Abramson Cancer Center at Penn Medicine

People needed

55

Starts

2023-05-08

Expected to finish

2024-11-09

Last updated by the study team

2025-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 years or older
• Based on cross-sectional imaging, suspected to have locally advanced/metastatic NSCLC (as determined by the evaluating clinician)
• Scheduled for an appointment in the lung cancer evaluation clinic

You may not qualify if…

• Are not suspected to have locally advanced/metastatic NSCLC
• Have a concurrent active malignancy

Where it is running

• Charu Aggarwal — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.